Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,544 | 357 | 69.4% |
| Consulting Fee | $3,180 | 1 | 29.3% |
| Education | $144.94 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $4,998 | 66 | $0 (2024) |
| ABBVIE INC. | $2,006 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $976.74 | 43 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $440.11 | 23 | $0 (2024) |
| Lilly USA, LLC | $384.64 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $298.16 | 11 | $0 (2024) |
| PFIZER INC. | $249.97 | 10 | $0 (2023) |
| Galderma Laboratories, L.P. | $237.36 | 24 | $0 (2024) |
| Amgen Inc. | $206.44 | 9 | $0 (2024) |
| Incyte Corporation | $149.83 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,527 | 134 | Dermavant Sciences, Inc. ($4,290) |
| 2023 | $1,938 | 97 | Dermavant Sciences, Inc. ($656.41) |
| 2022 | $1,277 | 62 | ABBVIE INC. ($585.06) |
| 2021 | $1,025 | 62 | AbbVie Inc. ($501.45) |
| 2020 | $101.54 | 5 | Regeneron Healthcare Solutions, Inc. ($46.10) |
All Payment Transactions
360 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $152.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 770 | 1,480 | $239,845 | $82,679 |
| 2022 | 17 | 852 | 1,713 | $291,521 | $99,489 |
| 2021 | 13 | 558 | 1,042 | $160,569 | $56,377 |
| 2020 | 1 | 18 | 20 | $3,600 | $1,368 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 217 | 400 | $85,100 | $30,625 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 73 | $21,940 | $8,385 | 38.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 52 | 78 | $21,593 | $7,329 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $20,403 | $6,676 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 74 | 130 | $21,068 | $6,416 | 30.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 67 | 72 | $17,803 | $5,737 | 32.2% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 15 | 58 | $9,721 | $2,821 | 29.0% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 20 | 22 | $6,675 | $2,566 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,305 | $2,343 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 50 | $6,709 | $2,263 | 33.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 48 | $6,663 | $1,925 | 28.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 46 | 293 | $4,668 | $1,792 | 38.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 15 | $5,019 | $1,745 | 34.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 29 | $3,528 | $1,369 | 38.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $2,418 | $608.64 | 25.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 106 | $230.00 | $79.57 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 231 | 400 | $87,209 | $31,297 | 35.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 113 | 113 | $31,034 | $10,447 | 33.7% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 18 | 85 | $25,351 | $10,051 | 39.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 79 | 91 | $23,363 | $7,512 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 44 | 83 | $23,618 | $7,358 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 60 | $18,338 | $6,431 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 63 | 121 | $20,294 | $5,885 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,994 | $3,142 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 64 | $8,898 | $3,124 | 35.1% |
About Dr. Sergey Petrosian, DO
Dr. Sergey Petrosian, DO is a Dermatology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1538520192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sergey Petrosian, DO has received a total of $10,868 in payments from pharmaceutical and medical device companies, with $6,527 received in 2024. These payments were reported across 360 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,544).
As a Medicare-enrolled provider, Petrosian has provided services to 2,198 Medicare beneficiaries, totaling 4,255 services with total Medicare billing of $239,914. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Brooklyn, NY
- Active Since 03/10/2016
- Last Updated 01/30/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1538520192
Products in Payments
- VTAMA (Drug) $4,998
- SKYRIZI (Biological) $1,085
- TREMFYA (Drug) $976.74
- RINVOQ (Biological) $744.93
- DUPIXENT (Biological) $410.10
- TALTZ (Drug) $352.49
- EUCRISA (Drug) $231.14
- ILUMYA (Biological) $207.25
- Otezla (Drug) $206.44
- OPZELURA (Drug) $149.83
- Winlevi (Drug) $149.51
- HUMIRA (Biological) $139.09
- Bimzelx (Biological) $138.34
- AKLIEF (Drug) $120.59
- Seysara (Drug) $98.98
- Sotyktu (Drug) $95.59
- ADBRY (Biological) $86.16
- Ilumya (Biological) $61.77
- ARAZLO (Drug) $60.74
- CYLTEZO (Biological) $55.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Brooklyn
Dr. Hilary Baldwin, M.d, M.D
Dermatology — Payments: $1.6M
Dr. Steven Baranowitz, Md, MD
Dermatology — Payments: $1.3M
Dr. Susan Bard, M.d, M.D
Dermatology — Payments: $291,896
Amanda Doyle, M.d, M.D
Dermatology — Payments: $176,297
Dr. Michael Jackson, M.d, M.D
Dermatology — Payments: $153,050
Sourab Choudhury, Do, DO
Dermatology — Payments: $45,155